MSD Partners’s TriSalus Life Sciences TLSI Stock Holding History

MSD Partners’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$182K	Hold	39,999	–	–	0.24%	9
2026 Q1	$160K	Hold	39,999	–	–	0.19%	8
2025 Q4	$279K	Hold	39,999	–	–	0.26%	7
2025 Q3	$186K	Hold	39,999	–	–	0.12%	7
2025 Q2	$218K	Hold	39,999	–	–	0.13%	7
2025 Q1	$221K	Hold	39,999	–	–	0.16%	9
2024 Q4	$200K	Hold	39,999	–	–	0.14%	9
2024 Q3	$184K	Buy	+39,999	New	+$212K	0.12%	14
2022 Q4	–	Sell	-400,000	Closed	-$3.97M	–	80
2022 Q3	$3.97M	Hold	400,000	–	–	0.32%	23
2022 Q2	$3.94M	Hold	400,000	–	–	0.24%	31
2022 Q1	$3.92M	Buy	+400,000	New	+$3.95M	0.21%	32

Other funds holding TLSI

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

MSD Partners's TLSI Position: Q2 2026 in Review

MSD Partners held its TriSalus Life Sciences (TLSI) position steady in Q2 2026 at 39,999 shares worth $182K. The position accounts for 0.24% of the portfolio, ranked #9.

MSD Partners first reported a position in TLSI in Q1 2022 and has held it in 11 quarters since. The position peaked at $3.97M in Q3 2022. 79 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

MSD Partners held 39,999 shares of TriSalus Life Sciences worth $182K as of Q2 2026.
MSD Partners left its TriSalus Life Sciences share count unchanged in Q2 2026.
TriSalus Life Sciences made up 0.24% of MSD Partners's portfolio in Q2 2026, its #9 holding.
MSD Partners first reported a position in TriSalus Life Sciences in Q1 2022 and has held it in 11 quarters since.
MSD Partners's TriSalus Life Sciences position peaked at $3.97M in Q3 2022.
79 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on MSD Partners's 13F filing for Q2 2026, filed 14 Aug 2026.